S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NWBO Northwest Biotherapeutics Inc (QB)

0.26

0.00235 (0.91%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Northwest Biotherapeutics (QB) Charts.

Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Northwest Biotherapeutics (QB) Charts.

Northwest Biotherapeutics Inc (QB) News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 13 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 9 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 8 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 2 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 30 July 2024 (5 months ago) • Edgar (US Regulatory)

Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher
Monday 17 June 2024 (6 months ago) • AllPennyStocks.com

Form 8-K - Current report
Tuesday 4 June 2024 (7 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 3 June 2024 (7 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Wednesday 22 May 2024 (7 months ago) • Edgar (US Regulatory)

More Northwest Biotherapeutics Inc (QB) News Articles

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions